ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,040.53
-0.50%
Dow Jones
44,544.66
-0.75%
US Dollar vs MXN
20.6826
0.00%
Brent Oil
76.385
0.00%
Bitcoin
99,044.97
-1.61%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC

  6. eFFECTOR Therapeutics Inc (CE) (EFTR) Cotización

eFFECTOR Therapeutics Inc (CE)

eFFECTOR Therapeutics Inc (CE) (EFTR)

USOTC
0.0002
0.00
(0.00%)
Cerrado 02 Febrero 3:00PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
0.0002
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
1,720
0.0002 Rango del Día 0.0002
0.000001 Rango de 52 semanas 0.17
Capitalización de Mercado [m]
940.882
Precio Anterior
0.0002
Precio de Apertura
0.0002
Hora
120
@
0.0002
Última hora de negociación
Volumen financiero
US$ 0
Precio Promedio Ponderado
0.0002
Volumen promedio (3 m)
13,735
Acciones en circulación
4,704,409
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.02
Beneficio por acción (BPA)
-7.61
turnover
-
Beneficio neto
-35.81M

Acerca de eFFECTOR Therapeutics Inc (CE)

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Wilmington, Delaware, USA
Fundado
-
eFFECTOR Therapeutics Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker EFTR. The last closing price for eFFECTOR Therapeutics (CE) was US$0. Over the last year, eFFECTOR Therapeutics (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.17.

eFFECTOR Therapeutics (CE) currently has 4,704,409 shares in issue. The market capitalisation of eFFECTOR Therapeutics (CE) is US$940.88 . eFFECTOR Therapeutics (CE) has a price to earnings ratio (PE ratio) of -0.02.

EFTR Últimas noticias

Más noticias

Form EFFECT - Notice of Effectiveness

01 Agosto 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

01 Agosto 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

01 Agosto 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

01 Agosto 2024
Edgar (US Regulatory)

Form 15-12G - Securities registration termination [Section 12(g)]

30 Julio 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

30 Julio 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

30 Julio 2024
Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement

30 Julio 2024
Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement

30 Julio 2024
Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement

30 Julio 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.00020.00020.000223510.0002CS
4000.00020.00021.0E-634740.00019427CS
12-0.0002-500.00040.00061.0E-6137350.0002181CS
26-0.0401-99.50372208440.04030.061.0E-6284180.02761711CS
52-0.0998-99.80.10.171.0E-6546240.05407545CS
156-0.0998-99.80.10.171.0E-6546240.05407545CS
260-0.0998-99.80.10.171.0E-6546240.05407545CS

EFTR - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de eFFECTOR Therapeutics (CE)?
El precio actual de las acciones de eFFECTOR Therapeutics (CE) es US$ 0.0002
¿Cuántas acciones de eFFECTOR Therapeutics (CE) están en circulación?
eFFECTOR Therapeutics (CE) tiene 4,704,409 acciones en circulación
¿Cuál es la capitalización de mercado de eFFECTOR Therapeutics (CE)?
La capitalización de mercado de eFFECTOR Therapeutics (CE) es USD 940.88
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de eFFECTOR Therapeutics (CE)?
eFFECTOR Therapeutics (CE) ha negociado en un rango de US$ 0.000001 a US$ 0.17 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de eFFECTOR Therapeutics (CE)?
El ratio precio/beneficio de eFFECTOR Therapeutics (CE) es -0.02
¿Cuál es la moneda de reporte de eFFECTOR Therapeutics (CE)?
eFFECTOR Therapeutics (CE) presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de eFFECTOR Therapeutics (CE)?
El último beneficio anual de eFFECTOR Therapeutics (CE) es USD -35.81M
¿Cuál es la dirección registrada de eFFECTOR Therapeutics (CE)?
La dirección registrada de eFFECTOR Therapeutics (CE) es CORPORATION TRUST CENTER, 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
¿En qué sector industrial opera eFFECTOR Therapeutics (CE)?
eFFECTOR Therapeutics (CE) opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
NXGBNxGen Brands Inc (CE)
US$ 0.003
(299,900.00%)
180.55k
DOCKFBeyond Med Technologies Inc (PK)
US$ 0.055
(54,900.00%)
3.05k
SDCCQSmileDirectClub Inc (CE)
US$ 0.0004
(39,900.00%)
52.05k
LTFDLittlefield Corporation (CE)
US$ 0.1525
(38,025.00%)
240
SGMDSugarmade Inc (CE)
US$ 0.0003
(29,900.00%)
5.94k
RTNBroot9B Holdings Inc (CE)
US$ 0.000001
(-99.97%)
666
THMOThermoGenesis Holdings Inc (CE)
US$ 0.000001
(-99.86%)
250
DOMWFPrime Drink Group Corporation (PK)
US$ 0.0012
(-99.08%)
311.03k
TTCMTautachrome Inc (CE)
US$ 0.000001
(-99.00%)
125.07k
MITJFMint Corporation (CE)
US$ 0.0001
(-99.00%)
12k
HCMCHealthier Choices Management Corporation (PK)
US$ 0.000001
(0.00%)
316.07M
HMBLHUMBL Inc (PK)
US$ 0.0007
(0.00%)
218.85M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(-25.00%)
210.68M
RONNRonn Motor Group Inc (PK)
US$ 0.0003
(0.00%)
171.31M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00275
(-1.79%)
134.31M

Discusión

Ver feed completo
Implanting Implanting 1 minuto hace
Interesting article on physical gold on the move. It's not just from the tariff scare.

https://www.zerohedge.com/news/2025-02-01/zh-reshoring-us-gold-has-nothing-do-trump-tariffs
FFMGF
Susie924 Susie924 1 minuto hace
Trump and Musk are feeding outrage to the media and the media is eating it up and asking for more.

I wonder what they are doing in the background while the media is in a frenzy.
Aquahoya Aquahoya 2 minutos hace
I was wrong. Clear as day. 
GSTC
al44 al44 5 minutos hace
From the Back Forty: Another Groundhog Day for Trump

We’ve been through this before, right?

by Sarah Cowgill | Feb 2, 2025

“The secret Republican plot to make liberals look like idiots, known as ‘Operation Just Let Them Speak,’ is clearly working.”
RickNagra RickNagra 6 minutos hace
Oh wow.  Big week on deck.  Press release and new updates in the works.  Exciting times ahead for all of us students and teachers and staff and shareholders in this space.  Educational component is well represented in this area.  After all only smart well educated people are buying great stocks such
GNCP
DiscoverGold DiscoverGold 8 minutos hace
Gold CoT: Peek Into Future Through Futures, How Hedge Funds Are Positioned
By: Hedgopia | February 1, 2025

• Following futures positions of non-commercials are as of January 28, 2025.

Gold: Currently net long 299.4k, down 1.4k.

hedgopia.com/wp
GDX
DiscoverGold DiscoverGold 9 minutos hace
NY Gold Futures »» Weekly Summary Analysis
By: Marty Armstrong | February 1, 2025

NY Gold Futures closed today at 28350 and is trading up about 7.34% for the year from last year's settlement of 26410. Up to this moment in time, this market has been rising for this month go
GDX
CatfishHunter CatfishHunter 9 minutos hace
Funny.  One thing MK doesn't do is release inside information. Most news of late has cause share price to trade down.  But keep stirring the pot if it makes you feel better.  
RDGL
gawti88 gawti88 9 minutos hace
45k base salary - Talk trash on boards.


haha how do you live with yourself.
CEOS
Margin Buu Margin Buu 9 minutos hace
It's funny because he doesn't deny it in his reply.
NWBO
ImjinBridger ImjinBridger 9 minutos hace
Jesus Christ
Are you addressing me??? I've had a lot of different monikers over the years, but never that. Trust me. It doesn't apply.
KBLB
DiscoverGold DiscoverGold 10 minutos hace
Gold & the Dow
By: Martin Armstrong | February 2, 2025

standard.socratesplatform.com/Blog/GetImage/679ed6a1c54f06123be89e33

While gold performed as expected, with Thursday being either the intraday high or the highest close, which is what happened, the nex
GOLD
arizona1 arizona1 10 minutos hace
I thought he was going to get rid of the Dept of Education.

https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:ur46cint3yxztzj42q4aqxjn/bafkreid2eedspciwjsevaws5yxwxmhnt75mpirw3pdam6vluxxhpwlekba@jpeg
Jetmek_03052 Jetmek_03052 10 minutos hace
Who really knows? It might actually all be true. But I'm not willing to deep six every other company that has spent billions on AI, because one Chinese company SAYS it has done the same thing for millions. It's not been proven. I also do not trust China. Its government is not to be trusted. I
NVDA
DiscoverGold DiscoverGold 10 minutos hace
Gold & the Dow
By: Martin Armstrong | February 2, 2025

standard.socratesplatform.com/Blog/GetImage/679ed6a1c54f06123be89e33

While gold performed as expected, with Thursday being either the intraday high or the highest close, which is what happened, the nex
LTListener LTListener 10 minutos hace
Good information. Highlights the value imbedded in the neuormodulator platform. It is interesting the amount of publication effort that continues to come forth. I am curious if whatever updates we end up getting as to if they have a plan to get CX-717 into clinicals for ADHD, which would be a ve
RSPI
ToddM ToddM 10 minutos hace
Chris you still alive? 
FLES
moola26 moola26 12 minutos hace
Bwahahahahaha. Yikes … McCoy totally ignored Biowin’s post! This is why we still hold

MAJORITY HOLDING STRONG$$$
Researchfyi Researchfyi 12 minutos hace
Absolutely, when you look at the bigger picture right now and compare the little successes and the growing of revenues within this part of the metals industry. LQMT is just the nat on the elephants ass.

However, if they can morph into the size of a mosquito right now, it would be enou
LQMT
AZCowboy AZCowboy 13 minutos hace
~ ADDED, & Finally ... the Original wamuq's, WMI's common shares OWNED The Washington Mutual Inc. "Holding Company" ... Period ~

as well as ... ALL That the Washington Mutual Inc. "Holding Company" ... received for its own financial participations, ... All described in one's Release'
COOP
barnyarddog barnyarddog 13 minutos hace
Now that's Entertainment !
FUBO
XMaster2023 XMaster2023 13 minutos hace
Who is kidding who? The Judge has been trying to get NWBO to settle for MONTHS. LP wants a JURY. It’s evident the Market Makers have caused severe harm to NWBO. The JURY WILL NOT BE GENTLE WITH THE MARKET MAKERS! WE ARE TALKING BILLIONS NOW TO SETTLE. Upon Approval, the settlement amount and or
NWBO
tedgoeseast tedgoeseast 14 minutos hace
Quit repeating your self I am getting tired of the same stupid post
cowtown jay cowtown jay 15 minutos hace
"USAID website goes offline in Trump administration’s 2-week-old freeze on foreign aid worldwide

USAID’s website has dropped offline without explanation in the Trump administration’s two-week-old funding freeze of U.S. foreign aid and development funding."

https://www.b

Su Consulta Reciente

USOTC
EFTR
eFFECTOR Therapeutics (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios